Michael P. Dube

Companies

• Intellia TherapeuticsPrincipal Accounting Officer Apr 22, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Intellia Therapeutics NTLA66,886 shares²$767.9K at $11.48Jul 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 1, 2026Sold 2,641 shares at $16.78 of Intellia Therapeutics²
• Mar 1, 2026Granted 17,250 shares of Intellia Therapeutics³
• Jan 5, 2026Sold 2,989 shares at $9.21 of Intellia Therapeutics⁴
• Oct 1, 2025Sold 1,871 shares at $17.38 of Intellia Therapeutics⁵
• Jul 2, 2025Sold 2,503 shares at $9.95 of Intellia Therapeutics⁶
• Mar 1, 2025Granted 14,000 shares of Intellia Therapeutics⁷
• Jan 3, 2025Sold 1,372 shares at $12.18 of Intellia Therapeutics⁸
• Oct 2, 2024Sold 2,012 shares at $19.01 of Intellia Therapeutics⁹
• Jul 1, 2024Granted 17,801 shares of Intellia Therapeutics¹⁰